Briumvi Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Toujeo (previously Optisulin) Unjoni Ewropea - Daniż - EMA (European Medicines Agency)

toujeo (previously optisulin)

sanofi-aventis deutschland gmbh - insulin glargin - diabetes mellitus - narkotika anvendt i diabetes - behandling af diabetes mellitus hos voksne, unge og børn fra 6 år.